Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysis. - Concepedia

Concepedia

Publication | Closed Access

Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysis.

44

Citations

0

References

2014

Year

Simon Peter Gampenrieder, Franz Romeder, Claudia Muß, Magdalena Pircher, Sigrun Ressler, Gabriel Rinnerthaler, Rupert Bartsch, Claudia Sattlberger, Brigitte Mlineritsch, Richard Greil

Abstract

Bevacizumab in addition to chemotherapy prolonged PFS and OS in a non-selected, partly intensively pre-treated breast cancer population. Hypertension induced by bevacizumab predicted therapy efficacy.